DGX
NYSEQUEST DIAGNOSTICS INC
Health Care, Health Care Services
$238.35
close 7 Aug 2026
+33.63%
52-week change
$26.31B
market cap
$171.18
$240.13
52-week range
Valuation
Market cap$26.31B
P/E (TTM / 5y avg)25.30x17.82x
Forward P/E (FY2026 / FY2027)21.30x19.77x
PEG (TTM / fwd)8.002.75
P/S (TTM)2.28x
P/B3.50x
EV/EBITDA (TTM)14.17x
FCF yield (TTM)5.13%
Cash flow & dividend
FCF (TTM)$1.35B
FCF per share (TTM)$12.22
FCF margin (TTM)11.67%
Dividend yield (indicated / 5y avg)1.44%1.90%
Annualized dividend$3.44
Payout ratio (EPS / FCF)34.18%26.91%
Growth & quality
Revenue YoY, latest Q+10.21%
Diluted EPS YoY, latest Q+14.98%
Operating margin (TTM)14.10%
Net margin (TTM)9.19%
ROE (latest FY)13.84%
Net debt / EBITDA (TTM)2.27
Interest coverage (TTM)—
Price
+60.81%+10.00%/yrover 5y
Weekly closes · split-adjusted
close 7 Aug 2026
Fundamentals
Fiscal years, last 10, CAGR chips on growth series, plus a dimmed trailing-twelve-month bar
Revenue
5Y CAGR +3.18%10Y CAGR +3.95%
Diluted EPS
5Y CAGR -3.53%10Y CAGR +6.03%
FCF per share
5Y CAGR +0.64%10Y CAGR +12.08%
Operating cash flow
5Y CAGR -1.22%10Y CAGR +8.67%
Free cash flow
5Y CAGR -3.05%10Y CAGR +9.31%
Dividends per share
5Y CAGR +7.46%10Y CAGR +7.90%
Payout ratio
FCF payout ratio
Operating margin
FCF margin
Return on equity
Return on capital employed
Shares outstanding
5Y CAGR -3.67%10Y CAGR -2.47%
Net debt / EBITDA
Interest coverage
Earnings
Street estimates, not SEC filings
Next / Q3 FY26
Date19 Oct 2026bmo
EPS estimate$2.88
Revenue estimate$3.07B
Last reported
Date—
EPS——
Revenue——